Miracco C, Pacenti L, Santopietro R, Laurini L, Biagioli M, Luzi P
Institute of Pathological Anatomy and Histology, University of Siena, Italy.
Hum Pathol. 2000 Sep;31(9):1018-21. doi: 10.1053/hupa.2000.9779.
Telomerase is an enzyme which synthesizes the telomeres, TTAGGG repeats at the end of vertebrate chromosomes. Its activity is suppressed in the majority of somatic cells, whereas it is detectable in most tumor cell lines and human cancers. Telomerase activity has been evaluated in many tumors for diagnostic purposes, and an increase thereof has been found with tumor progression. In our study we used anonisotopic polymerase chain reaction (PCR)-based TRAP (telomeric repeat amplification protocol) method to quantify the level of telomerase activity in a series of cutaneous melanocytic lesions. Thirty-three benign nevi, 8 dysplastic nevi, 38 malignant melanomas, and 4 melanoma metastases were analyzed. Mean relative telomerase activity was low in benign nevi (3.5+/-2.9), and significantly increased in dysplastic nevi (13.1+/-6.8), malignant melanomas (49.8+/-29.6), and metastases (121.2+/-11.2). In addition to the evaluation of telomerase activity as a possible diagnostic tool, its increase with tumor progression also suggest a prognostic role in cutaneous melanoma.
端粒酶是一种合成端粒的酶,端粒是脊椎动物染色体末端的TTAGGG重复序列。其活性在大多数体细胞中受到抑制,而在大多数肿瘤细胞系和人类癌症中可检测到。为了诊断目的,已经在许多肿瘤中评估了端粒酶活性,并且发现其活性随着肿瘤进展而增加。在我们的研究中,我们使用基于非同位素聚合酶链反应(PCR)的TRAP(端粒重复序列扩增协议)方法来量化一系列皮肤黑素细胞病变中端粒酶活性的水平。分析了33例良性痣、8例发育异常痣、38例恶性黑色素瘤和4例黑色素瘤转移灶。良性痣的平均相对端粒酶活性较低(3.5±2.9),发育异常痣(13.1±6.8)、恶性黑色素瘤(49.8±29.6)和转移灶(121.2±11.2)中显著升高。除了将端粒酶活性评估为一种可能的诊断工具外,其随着肿瘤进展而增加也提示在皮肤黑色素瘤中具有预后作用。